phosphoserine has been researched along with Kidney Diseases in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Involvement of p66shc in adverse effects of these drugs was determined in p66shc knockdown, Ser36 phosphorylation (S36A) and cytochrome c-binding (W134F)- deficient cells." | 1.39 | The role of p66shc in taxol- and dichloroacetic acid-dependent renal toxicity. ( Arany, I; Clark, JS; Ember, I; Juncos, LA; Reed, D; Szabó, I, 2013) |
| " Knockdown of p66shc, mutation of its Ser36 (S36A) or cytochrome c binding site (W134F) attenuated adverse effects of the two drugs." | 1.39 | The role of p66shc in taxol- and dichloroacetic acid-dependent renal toxicity. ( Arany, I; Clark, JS; Ember, I; Juncos, LA; Reed, D; Szabó, I, 2013) |
| "Taxol and DCA are potentially nephrotoxic owing their adverse effects on activation of p66shc." | 1.39 | The role of p66shc in taxol- and dichloroacetic acid-dependent renal toxicity. ( Arany, I; Clark, JS; Ember, I; Juncos, LA; Reed, D; Szabó, I, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arany, I | 1 |
| Clark, JS | 1 |
| Reed, D | 1 |
| Szabó, I | 1 |
| Ember, I | 1 |
| Juncos, LA | 1 |
1 other study available for phosphoserine and Kidney Diseases
| Article | Year |
|---|---|
The role of p66shc in taxol- and dichloroacetic acid-dependent renal toxicity.
Topics: Animals; Cytochromes c; Dichloroacetic Acid; Gene Knockdown Techniques; Kidney Diseases; Kidney Tubu | 2013 |